title: Alfacalcidol treatment in multiple sclerosis.
authors.forename: Anat
authors.initials: A
authors.lastname: Achiron
authors.forename: Yoram
authors.initials: Y
authors.lastname: Barak
authors.forename: Shmuel
authors.initials: S
authors.lastname: Miron
authors.forename: Yacov
authors.initials: Y
authors.lastname: Izhak
authors.forename: Meir
authors.initials: M
authors.lastname: Faibel
authors.forename: Shmuel
authors.initials: S
authors.lastname: Edelstein
mesh_terms: D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000097:blood / Q000188:drug therapy*
chemical_list: D006887:Hydroxycholecalciferols; C008088:alfacalcidol